Platelet response to aspirin 50 and 100 mg in patients with coronary heart disease over a five-year period

American Journal of Cardiology

Volumn 108, Issue 5, 2011, Pages 644-650

  Berent, Robert ^a   Auer, Johann ^b   Franklin, Barry ^c   Schmid, Peter ^a   Von Duvillard, Serge P ^a  

^a Center for Cardiovascular Rehabilitation   (Austria)

^b Department of Cardiology   (Austria)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; BETA THROMBOGLOBULIN; COLLAGEN; PROSTACYCLIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; TREATMENT RESPONSE;

ADULT; AGED; ANALYSIS OF VARIANCE; ASPIRIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 80051800551     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.04.011     Document Type: Article

References (30)

1. C. Baigent, C. Sudlow, R. Collins, and R. Peto Collaborative meta-analysis of randomised of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration BMJ 324 2002 71 86 (Pubitemid 34073138)
2. P.J. Mason, A.K. Jacobs, and J.E. Freedman Aspirin resistance and atherothrombotic disease J Am Coll Cardiol 46 2005 986 993 (Pubitemid 41316504)
3. C. Patrono, C. Baigent, J. Hirsh, and G. Roth Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 2008 199 233
4. F.M. Pulcinelli, P. Pignatelli, A. Celestini, S. Riondino, P.P. Gazzaniga, and F. Violi Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients J Am Coll Cardiol 43 2004 979 984 (Pubitemid 38352975)
5. U. Berglund, and L. Wallentin Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease Eur Heart J 12 1991 428 433
6. C.M. Helgason, K.M. Bolin, J.A. Hoff, S.R. Winkler, A. Mangat, K.L. Tortorice, and L.D. Brace Development of aspirin resistance in persons with previous ischemic stroke Stroke 25 1994 2331 2336 (Pubitemid 24359298)
7. K. Fox, M.A. Garcia, D. Ardissino, P. Buszman, P.G. Camici, F. Crea, C. Daly, G. De Backer, P. Hjemdahl, J. Lopez-Sendon, J. Marco, J. Morais, J. Pepper, U. Sechtem, M. Simoons, K. Thygesen, S.G. Priori, J.J. Blanc, A. Budaj, J. Camm, V. Dean, J. Deckers, K. Dickstein, J. Lekakis, K. McGregor, M. Metra, J. Morais, A. Osterspey, J. Tamargo, and J.L. Zamorano Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381 (Pubitemid 43998110)
8. International Council for Standardization in Haematology (Expert Panel on Blood Rheology) ICSH recommendations for measurement of erythrocyte sedimentation rate J Clin Pathol 46 1993 198 203
9. A. Clauss Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens Acta Haematol (Basel) 17 1957 237 246
10. G.V. Born, and M.J. Cross The aggregation of blood platelets J Physiol (Lond) 168 1963 178 195
11. 2 in patients chronically treated with aspirin J Thromb Haemost 3 2005 2784 2789 (Pubitemid 41819808)
12. A.O. Maree, R.J. Curtin, M. Dooley, R.M. Conroy, P. Crean, D. Cox, and D.J. Fitzgerald Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease J Am Coll Cardiol 46 2005 1258 1263 (Pubitemid 41615546)
13. A.Y. Gasparyan, T. Watson, and G.Y. Lip The role of aspirin in cardiovascular prevention: implications of aspirin resistance J Am Coll Cardiol 51 2008 1829 1843 (Pubitemid 351615246)
14. M. Hurlen, I. Seljeflot, and H. Arnesen Increased platelet aggregability during exercise in patients with previous myocardial infarction Lack of inhibition by aspirin Thromb Res 99 2000 487 494
15. P.T. Larsson, N.H. Wallén, and P. Hjemdahl Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin Circulation 89 1994 1951 1957 (Pubitemid 24142768)
16. J.W. Eikelboom, J.G. Hankey, J. Thom, D.L. Bhatt, P.G. Steg, G. Montalescot, S.C. Johnston, S.R. Steinhubl, K.H. Mak, J.D. Easto, C. Hamm, T. Hu, K.A.A. Fox, and E.J. Topol Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk Circulation 118 2008 1705 1712
17. M.T. Santos, M.P. Fuset, M. Ruano, A. Moscardó, and J. Valles Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction Am J Cardiol 104 2009 1618 1623
18. A.O. Maree, R.J. Curtin, A. Chubb, C. Dolan, D.O. Cox, J. Brien, P. Crean, D.C. Shileds, and D.J. Fitzgerald Cyclooxygenase-1 haplotype modulates platelet response to aspirin J Thromb Haemost 3 2005 2340 2345 (Pubitemid 41727215)
19. U.S. Tantry, K.P. Bliden, and P.A. Gurbel Overestimation of platelet aspirin resistance detection by thromboelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation J Am Coll Cardiol 46 2005 1705 1709 (Pubitemid 41531626)
20. J.W. Eikelboom, J. Hirsh, J.I. Weitz, M. Johnston, Q. Yi, and S. Yusuf Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650 1655 (Pubitemid 34298607)
21. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369 (Pubitemid 36158034)
22. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565 (Pubitemid 35315836)
23. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood 109 2007 2285 2292 (Pubitemid 46425865)
24. R.A. Ajjan, K.F. Standeven, M. Khanbhai, F. Phoenix, K.C. Gersh, J.W. Weisel, M.T. Kearney, R.A. Arins, and P.J. Grant Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system Arterioscler Thromb Vasc Biol 29 2009 712 717
25. G.R. Upchurch Jr, N. Ramdev, M.T. Walsh, and J. Loscalzo Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin J Thromb Thrombolysis 5 1998 9 14 (Pubitemid 28075248)
26. J.P. Collet, Y. Allali, C. Lesty, M.L. Tanguy, J. Silvain, A. Ankri, B. Blanchet, R. Dumaine, J. Gianetti, L. Payot, J.W. Weisel, and G. Montalescot Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis Arterioscler Thromb Vasc Biol 26 2006 2567 2573 (Pubitemid 44607482)
27. D. Tousoulis, M. Charakida, and C. Stefanadis Endothelial function and inflammation in coronary artery disease Heart 92 2006 441 444
28. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
29. I. Tzoulaki, G.D. Murray, A.J. Lee, A. Rumley, G.D. Lowe, and F.G. Fowkes C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study Circulation 112 2005 976 983 (Pubitemid 41170265)
30. P. Sorajja, B.J. Gersh, D.A. Cox, M.G. McLaughlin, P. Zimetbaum, C. Constantini, T. Stuckey, J.E. Tcheng, R. Mehran, A.J. Lansky, C.L. Grines, and G.W. Stone Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction Eur Heart J 28 2007 1709 1716 (Pubitemid 47227095)